Prophylactic Central Compartment Node Dissection for Papillary Thyroid Carcinoma: Complication and Outcome.
10.16956/kjes.2011.11.4.262
- Author:
Jun Soo JEONG
1
;
Jin Young LEE
;
Sang Jeon LEE
;
Sung Soo KOONG
;
Jin Woo PARK
Author Information
1. Department of Surgery, Chungbuk National University, Cheongju, Korea. webjwpark@chungbuk.ac.kr
- Publication Type:Original Article
- Keywords:
Prophylactic central compartment node dissection;
Papillary thyroid cancer;
Complication;
Hypoparathyroidism;
Disease free survival
- MeSH:
Disease-Free Survival;
Follow-Up Studies;
Humans;
Hypoparathyroidism;
Lymph Nodes;
Neoplasm Metastasis;
Recurrence;
Recurrent Laryngeal Nerve Injuries;
Thyroid Gland*;
Thyroid Neoplasms*;
Thyroidectomy
- From:Korean Journal of Endocrine Surgery
2011;11(4):262-268
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Prophylactic central compartment node dissection is gaining acceptance in the treatment of papillary thyroid carcinoma (PTC). However, its benefits remain controversial. The aim of study was to evaluate the effects of prophylactic central compartment node dissection on the complication rate and the short-term disease-free survival rate. METHODS: Our treatment strategy for PTC without clinical evidence of lymph node metastasis has been changed from total thyroidectomy alone (group I) to total thyroidectomy with prophylactic central compartment node dissection (group II) since January 2007. Before and after 2007, 70 consecutive patients were selected in each group. RESULTS: The average age of patients was 46.3±11.8 years. Average follow-up period was 51.9±10.9 months. The average size of maximum diameters of the tumors was 1.3±0.8 cm. Lymph node metastasis was identified in 22.9% of patients in group II. Recurrent laryngeal nerve injury occurred in one patient in each group. Temporary and permanent hypoparathyroidism occurred in 32.9% and 2.9% in group I, 40.0% and 7.1% in group II respectively (P=0.483 and P=0.441, respectively). Locoregional recurrences developed in seven patients in group I. Fifty month disease-free survival rate was 90.0% and 100% in group I and group II, respectively (P=0.0078). CONCLUSION: Prophylactic central compartment node dissection did not seem to increase the risk of recurrent laryngeal nerve injury, but may increase the risk of temporary and permanent hypoparathyroidism. Prophylactic central compartment node dissection decreased the risk of locoregional recurrences, especially in central compartment. However, the size of metastatic lymph nodes in central compartment in the present study was relatively small and their clinical implication remains to be evaluated.
